Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Profit After Tax (2023 - 2025)

Immunocore Holdings' Profit After Tax history spans 3 years, with the latest figure at -$30.1 million for Q4 2025.

  • For Q4 2025, Profit After Tax fell 26.46% year-over-year to -$30.1 million; the TTM value through Dec 2025 reached -$35.5 million, up 30.48%, while the annual FY2025 figure was -$35.5 million, 30.48% up from the prior year.
  • Profit After Tax for Q4 2025 was -$30.1 million at Immunocore Holdings, down from -$177000.0 in the prior quarter.
  • Across five years, Profit After Tax topped out at $8.7 million in Q3 2024 and bottomed at -$30.1 million in Q4 2025.
  • The 3-year median for Profit After Tax is -$14.3 million (2023), against an average of -$11.8 million.
  • The largest annual shift saw Profit After Tax soared 864.24% in 2024 before it plummeted 102.03% in 2025.
  • A 3-year view of Profit After Tax shows it stood at -$19.7 million in 2023, then decreased by 20.48% to -$23.8 million in 2024, then fell by 26.46% to -$30.1 million in 2025.
  • Per Business Quant, the three most recent readings for IMCR's Profit After Tax are -$30.1 million (Q4 2025), -$177000.0 (Q3 2025), and -$10.3 million (Q2 2025).